# 68180-659-06 · Rifampin Capsule · Lupin Pharmaceuticals, Inc. — FDA drug shortage duration tracker

For 68180-659-06 · Rifampin Capsule · Lupin Pharmaceuticals, Inc., package ndc is 68180-659-06; generic name is Rifampin Capsule; manufacturer is Lupin Pharmaceuticals, Inc; status is Current; availability now is Available, recorded from its source on 2026-09-01.

- **Package NDC:** 68180-659-06 _(verified: appears in the quote below)_
- **Generic name:** Rifampin Capsule _(verified: appears in the quote below)_
- **Manufacturer:** Lupin Pharmaceuticals, Inc. _(verified: appears in its own passage below)_
- **Status:** Current _(verified: appears in its own passage below)_
- **Availability now:** Available _(verified: appears in the quote below)_
- **Initial posting date:** 12/22/2021 _(verified: appears in the quote below)_
- **Last update date:** 08/18/2026 _(verified: appears in its own passage below)_
- **Days in shortage:** 1714 _(our reading, not quoted from the source)_
- **Dosage form:** Capsule _(verified: appears in its own passage below)_
- **Therapeutic category:** Anti-Infective _(verified: appears in its own passage below)_

## What the source says

> "initial_posting_date": "12/22/2021", "package_ndc": "68180-659-06", "generic_name": "Rifampin Capsule", "contact_info": "866-587-4617", "availability": "Available"

## Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

### Manufacturer

> "update_date": "08/18/2026", "therapeutic_category": [ "Anti-Infective" ], "dosage_form": "Capsule", "presentation": "Rifampin, Capsule, 300 mg (NDC 68180-659-06)", "company_name": "Lupin Pharmaceuticals, Inc.", "status": "Current"

### Status

> "update_date": "08/18/2026", "therapeutic_category": [ "Anti-Infective" ], "dosage_form": "Capsule", "presentation": "Rifampin, Capsule, 300 mg (NDC 68180-659-06)", "company_name": "Lupin Pharmaceuticals, Inc.", "status": "Current"

### Last update date

> "update_date": "08/18/2026", "therapeutic_category": [ "Anti-Infective" ], "dosage_form": "Capsule", "presentation": "Rifampin, Capsule, 300 mg (NDC 68180-659-06)", "company_name": "Lupin Pharmaceuticals, Inc.", "status": "Current"

### Dosage form

> "update_date": "08/18/2026", "therapeutic_category": [ "Anti-Infective" ], "dosage_form": "Capsule", "presentation": "Rifampin, Capsule, 300 mg (NDC 68180-659-06)", "company_name": "Lupin Pharmaceuticals, Inc.", "status": "Current"

### Therapeutic category

> "update_date": "08/18/2026", "therapeutic_category": [ "Anti-Infective" ], "dosage_form": "Capsule", "presentation": "Rifampin, Capsule, 300 mg (NDC 68180-659-06)", "company_name": "Lupin Pharmaceuticals, Inc.", "status": "Current"

## Source

- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lupin%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Rifampin%20Capsule%22+AND+status%3A%22Current%22&limit=1000

Last verified: 2026-09-01. Review by: 2026-09-04.
Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).